363 related articles for article (PubMed ID: 38785534)
1. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.
Hickey JP; Collins AE; Nelson ML; Chen H; Kalisch BE
Curr Issues Mol Biol; 2024 May; 46(5):4379-4402. PubMed ID: 38785534
[TBL] [Abstract][Full Text] [Related]
2.
Watt G; Karl T
Front Pharmacol; 2017; 8():20. PubMed ID: 28217094
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol for neurodegenerative disorders: A comprehensive review.
Bhunia S; Kolishetti N; Arias AY; Vashist A; Nair M
Front Pharmacol; 2022; 13():989717. PubMed ID: 36386183
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.
Karl T; Garner B; Cheng D
Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):142-160. PubMed ID: 27471947
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging.
Liu Y
Mol Biol Rep; 2024 Jan; 51(1):121. PubMed ID: 38227160
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
Yousaf M; Chang D; Liu Y; Liu T; Zhou X
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol protects mouse hippocampal neurons from neurotoxicity induced by amyloid β-peptide
Salgado KDCB; Nascimento RGF; Coelho PJFN; Oliveira LAM; Nogueira KOPC
Toxicol In Vitro; 2024 Jun; 99():105880. PubMed ID: 38901785
[TBL] [Abstract][Full Text] [Related]
8. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
Cheng D; Spiro AS; Jenner AM; Garner B; Karl T
J Alzheimers Dis; 2014; 42(4):1383-96. PubMed ID: 25024347
[TBL] [Abstract][Full Text] [Related]
9.
Viana MB; de Aquino PEA; Estadella D; Ribeiro DA; Viana GSB
Med Cannabis Cannabinoids; 2022; 5(1):207-219. PubMed ID: 36467781
[TBL] [Abstract][Full Text] [Related]
10. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
Singh K; Bhushan B; Chanchal DK; Sharma SK; Rani K; Yadav MK; Porwal P; Kumar S; Sharma A; Virmani T; Kumar G; Noman AA
Behav Neurol; 2023; 2023():8825358. PubMed ID: 37868743
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
Tambe SM; Mali S; Amin PD; Oliveira M
J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
[TBL] [Abstract][Full Text] [Related]
12. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
[TBL] [Abstract][Full Text] [Related]
13. From
Cassano T; Villani R; Pace L; Carbone A; Bukke VN; Orkisz S; Avolio C; Serviddio G
Front Pharmacol; 2020; 11():124. PubMed ID: 32210795
[No Abstract] [Full Text] [Related]
14. Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.
Coles M; Steiner-Lim GZ; Karl T
Front Neurosci; 2022; 16():962922. PubMed ID: 36117622
[TBL] [Abstract][Full Text] [Related]
15. An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects.
Martinez Naya N; Kelly J; Corna G; Golino M; Polizio AH; Abbate A; Toldo S; Mezzaroma E
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257386
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations.
Aziz AI; Nguyen LC; Oumeslakht L; Bensussan A; Ben Mkaddem S
Cannabis Cannabinoid Res; 2023 Apr; 8(2):254-269. PubMed ID: 36413346
[No Abstract] [Full Text] [Related]
17. Understanding the Modulatory Effects of Cannabidiol on Alzheimer's Disease.
Xiong Y; Lim CS
Brain Sci; 2021 Sep; 11(9):. PubMed ID: 34573232
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol.
Oliveira BSA; Milanezi DS; Gonzaga PDV; Detoni FR; Soriano RN
Heliyon; 2022 Dec; 8(12):e12172. PubMed ID: 36544841
[TBL] [Abstract][Full Text] [Related]
19. Assessing Cannabidiol as a Therapeutic Agent for Preventing and Alleviating Alzheimer's Disease Neurodegeneration.
Chen L; Sun Y; Li J; Liu S; Ding H; Wang G; Li X
Cells; 2023 Nov; 12(23):. PubMed ID: 38067101
[TBL] [Abstract][Full Text] [Related]
20. Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Aβ40 Levels in 12-Month-Old Male AβPPswe/PS1ΔE9 Transgenic Mice.
Watt G; Shang K; Zieba J; Olaya J; Li H; Garner B; Karl T
J Alzheimers Dis; 2020; 74(3):937-950. PubMed ID: 32116258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]